Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction

NCT ID: NCT05100264

Last Updated: 2024-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

230 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-29

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acidification of vaginal pH has been proposed as a potential factor that could help increase the efficacy of vaginal prostaglandins in labor induction. The aim of the present randomized controlled trial is to evaluate the impact of an acidic vaginal pH on the progress of labor induction with dinoprostone (Prostaglandin E2 - PGE2) vaginal tablet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Labor, Induced Induced; Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Randomization will be computer generated. Allocation concealment will be ensured by opaque sealed envelopes. Blinding of outcomes assessor, principal as well as other investigators will be ensured as randomization will be performed by an external investigator that will not participate in the clinical process of the study or the statistical analysis. The ward midwife will open the randomization envelope after patient enrollment and different types of vaginal washing will be applied as per randomization. Participant as well outcomes assessor (physician that will evaluate the progress of labor as well statistician involved in the analysis) will be blinded to the procedure.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vaginal washing 5% acetic acid

Group Type EXPERIMENTAL

Vaginal washing with 5% acetic acid

Intervention Type OTHER

Induction of labor (vaginal tablet dinoprostone and vaginal washing with 5% acetic acid)

Vaginal washing 0.9% N/S

Group Type PLACEBO_COMPARATOR

Vaginal washing with 0.9% NS

Intervention Type OTHER

Induction of labor (vaginal tablet dinoprostone and vaginal washing 0.9% NS)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vaginal washing with 5% acetic acid

Induction of labor (vaginal tablet dinoprostone and vaginal washing with 5% acetic acid)

Intervention Type OTHER

Vaginal washing with 0.9% NS

Induction of labor (vaginal tablet dinoprostone and vaginal washing 0.9% NS)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton pregnancy
* Full term (\>37 weeks)
* Cephalic presentation
* Reactive NST (nonstress test)
* Absence of spontaneous uterine contractions
* No contraindications to vaginal delivery

Exclusion Criteria

* Multifetal pregnancy
* Fetal malpresentation
* Preterm delivery (\<37 weeks)
* Advanced maternal age (\>40 years)
* Bishop score \> 7
* Fetal macrosomia ( \>4500 gr)
* Non reassuring NST (nonstress test)
* Suspected chorioamnionitis
* Previous cesarean delivery or other uterine surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National and Kapodistrian University of Athens

OTHER

Sponsor Role collaborator

Alexandra Hospital, Athens, Greece

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georgios Daskalakis

Professor of Obstetrics and Gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgios Daskalakis

Role: STUDY_DIRECTOR

Alexandra General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alexandra General Hospital

Athens, , Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

68/7/22-9-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prostin and Propess in Induction of Labor
NCT01635439 COMPLETED PHASE3